Recruiting NCT06693700
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Indoor Air Quality Monitor AirGradient ONE.
- Who it may be relevant to
- Registry conditions: Smoking, Smoking Cessation, Smoking Reduction, Smoking Habit. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families
Overview
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
Interventions
- Other Indoor Air Quality Monitor AirGradient ONE
Participants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.
Primary outcome measures
- Percentage of participants using the air quality monitoring device for 14 consecutive days [Time frame: up to 8 weeks]
- Percentage of participants who attend the study-specific smoke-free workshop sessions [Time frame: Up to 8 weeks]
Eligibility criteria
Inclusion criteria
- Adult (aged >18 years) MSK patients as per the EHR
- Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
- Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
- Must be English-speaking in the EHR
- Must be reachable by phone as per self-report
- Must have Wi-Fi available at home as per self-report
Exclusion criteria
- Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
United States · 8 centers
- Memorial Sloan Kettering Basking Ridge (Consent only) — Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only) — Middletown
- Memorial Sloan Kettering Bergen (Consent only) — Montvale
- Memorial Sloan Kettering Suffolk-Commack (Consent only) — Commack
- Memorial Sloan Kettering Westchester (Consent only) — Harrison
- City College of New York (Data Collection AND Data Analysis) — New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York
- Memorial Sloan Kettering Nassau (Consent only) — Uniondale
Identifiers
NCT: NCT06693700 · 24-260